Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical R&D company that has developed and patented Invisicare, a polymer delivery system that enhances topical delivery of active ingredients. The company has formulated over forty topical skin products, which it out-licenses globally to pharmaceutical and consumer goods companies, generating revenue through licensing fees, royalties, co-development, and life cycle management services.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001663577-26-000087 | EDGAR | 25K words |
| 2025-04-14 | 2024-12-31 | 0001663577-25-000110 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001663577-24-000119 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001663577-23-000137 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001663577-22-000171 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001663577-21-000186 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001663577-20-000147 | EDGAR | — |
| 2019-04-15 | 2018-12-31 | 0001663577-19-000163 | EDGAR | — |
| 2018-03-23 | 2017-12-31 | 0001663577-18-000138 | EDGAR | — |
| 2017-04-17 | 2016-12-31 | 0001663577-17-000119 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001663577-25-000309 | EDGAR | 13K words |
| 2025-08-13 | 2025-06-30 | 0001663577-25-000261 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001663577-25-000136 | EDGAR | — |
| 2024-11-19 | 2024-09-30 | 0001663577-24-000294 | EDGAR | — |
| 2024-08-15 | 2024-06-30 | 0001663577-24-000234 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001663577-24-000137 | EDGAR | — |
| 2023-11-15 | 2023-09-30 | 0001663577-23-000536 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001663577-23-000402 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001663577-23-000234 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001663577-22-000653 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001663577-22-000441 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001663577-22-000312 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-01-23 | 0001663577-25-000033 | EDGAR | 1K words |
| 2024-10-03 | 0001663577-24-000257 | EDGAR | — |
| 2024-06-04 | 0001663577-24-000148 | EDGAR | — |
| 2024-05-29 | 0001663577-24-000143 | EDGAR | — |
| 2023-10-25 | 0001663577-23-000514 | EDGAR | — |
| 2022-01-13 | 0001663577-22-000032 | EDGAR | — |
| 2020-05-14 | 0001663577-20-000149 | EDGAR | — |
| 2020-04-14 | 0001663577-20-000092 | EDGAR | — |
| 2019-10-22 | 0001663577-19-000381 | EDGAR | — |
| 2019-04-19 | 0001663577-19-000175 | EDGAR | — |
137 total filings indexed. 105 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001085277 |
| Ticker | SKVI |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report